Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 15, 2020
Rafarma Pharmaceuticals has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia.
read more
Rafael Pharmaceuticals has entered into an out-licensing agreement with Ono Pharmaceutical.
read more
Rafael Pharmaceuticals, Inc. announced that it is changing its name to Cornerstone Pharmaceuticals, Inc. (“Cornerstone”), its original company name. All company branding, including the website and logo have been updated accordingly.
read more
Radyus Research and Eurofins CDMO Alphora announced a new strategic partnership to help accelerate early-stage drug development for biotech companies worldwide.
read more
Wednesday, November 02, 2016
RadioMedix Inc. and AREVA Med have been awarded a collaborative Small Business Innovation Research (SBIR) Contract Grant by the National Institutes of Health, National Cancer Institute to evaluate targeted alpha-emitter therapy of neuroendocrine ...
read more
Wednesday, September 14, 2016
Radiant Clinical Research, one of the country’s largest and fastest-growing network of wholly owned integrated clinical trial sites, has announced that Rebecca Little has joined the company as Director of Business Development.
read more
Radiant Clinical Research is expanding the scope of its Central Nervous System (CNS) studies. This expansion is in response to a growing need for qualified sites that have the expertise to conduct pharmaceutical trials for the treatment of ...
read more
Tuesday, September 15, 2020
The two organizations form an agile and scalable consulting firm dedicated to their combined focus areas in the life science industry.
read more
Following cGMP audit of QuVa Pharma's Sugar Land and Temple, Texas facilities, the California Board of Pharmacy has issued Outsource Facility licenses to both QuVa locations.
read more
Wednesday, September 27, 2017
QuVa Pharma has received FDA registration as a 503B facility for its Bloomsbury, New Jersey facility.
read more
QuVa Pharma, Inc., a recently formed national platform for sterile compounding pharmacy services, has signed an agreement to acquire an FDA approved biotech pharmaceutical facility in New Jersey.
read more
QuVa Pharma has added another forward distribution center to its existing 503B sterile injectable compounded medications platform. Quva now has two dedicated forward distribution facilities, with the new 20,000 sq. ft. distribution facility in Sugar ...
read more
Wednesday, April 29, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials has been announced by Quotient Sciences and CytoAgents.
read more
Quotient Sciences announced an extended commercial supply partnership with Ipsen, a global biopharmaceutical company, to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 people ...
read more
Monday, February 13, 2023
Quotient Sciences announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility.
read more